In most mammalian cells, the retinoic acid receptor (RAR) is nuclear rather than cytoplasmic, regardless of its cognate ligand, retinoic acid (RA). In testis Sertoli cells, however, RAR is retained in the cytoplasm and moves to the nucleus only when RA is supplied. This led us to identify a protein that regulates the translocation of RAR. From yeast two-hybrid screening, we identified a novel RAR-interacting protein called CART1 (cytoplasmic adaptor for RAR and TR). Systematic interaction assays using deletion mutants showed that the C-terminal CoRNR box of CART1 was responsible for the interaction with the NCoR binding region of RAR and TR. Such interaction was impaired in the presence of ligand RA, as further determined by GST pulldown assays in vitro and immunoprecipitation assays in vivo. Fluorescence microscopy showed that unliganded RAR was captured by CART1 in the cytoplasm, whereas liganded RAR was liberated and moved to the nucleus. Overexpression of CART1 blocked the transcriptional repressing activity of unliganded apoRAR, mediated by corepressor NCoR in the nucleus. CART1 siRNA treatment in a mouse Sertoli cell line, TM4, allowed RAR to move to the nucleus and blocked the derepressing function of CART1, suggesting that CART1 might be a cytoplasmic, testisspecific derepressor of RAR.Nuclear receptors (NRs) 3 are ligand-dependent transcription factors that control diverse aspects of development and homeostasis by regulating expression of their target genes (1, 2). The NR superfamily, which shares a common structural organization composed of distinct domains, is classified into three groups, steroid hormone receptors, non-steroid hormone receptors, and orphan receptors. One of the major regulatory effects of NRs can be achieved by a change in subcellular location in response to various cellular factors. Steroid hormone receptors, such as glucocorticoid receptor and estrogen receptor, reside in the cytoplasm in association with heat shock protein 90 (Hsp90) but on the entry of their cognate ligands dissociate from Hsp90 and translocate to the nucleus to exert transcriptional activation (3-6). However, non-steroid hormone receptors, such as RAR and TR, reside solely in the nucleus regardless of their ligands in most mammalian cells. In the absence of ligands, these receptors transverse the nuclear membrane and associate with nuclear corepressors, such as nuclear receptor corepressor (NCoR1) or silencing mediator for retinoid and thyroid hormone receptors (SMRT or NCoR2) to mediate transcriptional repression (7,8). These corepressors then recruit histone deacetylase, resulting in histone deacetylaton, chromatin compaction, and silencing of target gene expression (9, 10). In the presence of ligands, corepressors dissociate, and instead, coactivators with histone acetyltransferase activity associate to mediate transcriptional activation (11,12). Despite significant progress in understanding nuclear regulation of RAR and TR, little is known about their regulation in the cytoplasm. A few reports have suggest...